[go: up one dir, main page]

MX2010001841A - Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas. - Google Patents

Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas.

Info

Publication number
MX2010001841A
MX2010001841A MX2010001841A MX2010001841A MX2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A MX 2010001841 A MX2010001841 A MX 2010001841A
Authority
MX
Mexico
Prior art keywords
endophthalmitis
compositions
methods
modulating
fluoroquinolones
Prior art date
Application number
MX2010001841A
Other languages
English (en)
Inventor
Keith Wayne Ward
Jinzhong Zhang
Matthew Scott Jonasse
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of MX2010001841A publication Critical patent/MX2010001841A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Las composiciones para modular la endoftalmitis comprenden una fluoroquinolona que tiene una de las fórmulas l-VIII. Los métodos para modular la endoftalmitis comprenden administrar estas composiciones a un sujeto necesitado de las mismas. Las composiciones y métodos son adecuados para modular la endoftalmitis pos-operativa, endoftalmitis postraumática, endoftalmitis no infecciosa, panoftalmitis, endoftalmitis hematogénica y combinaciones de las mismas.
MX2010001841A 2007-08-21 2008-08-08 Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas. MX2010001841A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95700507P 2007-08-21 2007-08-21
PCT/US2008/072552 WO2009026009A1 (en) 2007-08-21 2008-08-08 Compositions and methods for modulating endophthalmitis using fluoroquinolones

Publications (1)

Publication Number Publication Date
MX2010001841A true MX2010001841A (es) 2010-03-10

Family

ID=39886006

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001841A MX2010001841A (es) 2007-08-21 2008-08-08 Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas.

Country Status (12)

Country Link
US (1) US20090054406A1 (es)
EP (1) EP2178535B1 (es)
JP (1) JP2010536860A (es)
KR (1) KR101227230B1 (es)
CN (1) CN101784275A (es)
AU (1) AU2008289347B2 (es)
BR (1) BRPI0815599A2 (es)
CA (1) CA2696613C (es)
ES (1) ES2392208T3 (es)
MX (1) MX2010001841A (es)
TW (1) TW200918075A (es)
WO (1) WO2009026009A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010104941A2 (en) 2009-03-11 2010-09-16 Deepflex Inc. Method and apparatus to repair flexible fiber-reinforced pipe
US20180221407A1 (en) * 2017-02-03 2018-08-09 The Administrators Of The Tulane Educational Fund Ophthalmic compositions for therapeutic and prophylactic uses
EP3766967B1 (en) 2018-03-12 2025-03-26 National University Corporation Kochi University Novel bacteriophage and treatment agent for bacterial endophthalmitis
CN119546278A (zh) * 2022-05-18 2025-02-28 格劳科斯公司 两性离子在眼用局部乳膏组合物和制剂中的新应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US6699492B2 (en) * 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6646003B2 (en) * 2001-04-02 2003-11-11 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
WO2004097410A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Screening methods for cataractogenic risk
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
BRPI0808823A2 (pt) * 2007-03-21 2017-10-10 Bausch & Lomb composição e método para tratar, reduzir, melhorar ou prevenir uma infecção.

Also Published As

Publication number Publication date
CA2696613C (en) 2012-09-18
AU2008289347A1 (en) 2009-02-26
HK1140700A1 (en) 2010-10-22
US20090054406A1 (en) 2009-02-26
JP2010536860A (ja) 2010-12-02
AU2008289347B2 (en) 2011-12-08
EP2178535A1 (en) 2010-04-28
TW200918075A (en) 2009-05-01
ES2392208T3 (es) 2012-12-05
BRPI0815599A2 (pt) 2015-03-03
CN101784275A (zh) 2010-07-21
EP2178535B1 (en) 2012-09-19
WO2009026009A1 (en) 2009-02-26
CA2696613A1 (en) 2009-02-26
KR101227230B1 (ko) 2013-01-28
KR20100034049A (ko) 2010-03-31

Similar Documents

Publication Publication Date Title
SG194469A1 (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
MX359639B (es) Metodos y composiciones para uso en tratamientos celulares.
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
UA109010C2 (en) Morpholino pyrividines and their use in therapy
PH12015501661B1 (en) Pyridone amides as modulators of sodium channels
PH12014500053A1 (en) Proteasome inhibitors
MX366130B (es) Inhibidores bivalentes de las proteinas iap y métodos terapéuticos que usan los mismos.
PH12013500955A1 (en) Spiro-oxindole mdm2 antagonists
TN2010000236A1 (en) Fused pyridine pyrimidine and triazine compounds as cell cycle inhibitors
MX343688B (es) Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
MX2015015518A (es) Metodos y composiciones para el tratamiento del cancer.
MY162146A (en) Pharmaceutical composition
MX2014008706A (es) Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
MX2010003009A (es) Piridil sulfonamidas como moduladores de canales ionicos.
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
MY191932A (en) Chitosan-derived compositions
UA114417C2 (uk) Інгібітори iap
PH12016500136B1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
SA519401424B1 (ar) Cmet عوامل ربط أحادية النسيلة، مترافقات عقار منها واستخداماتها
MY191337A (en) Compositions for the treatment of hypertension and/or fibrosis
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX2010001841A (es) Composiciones y metodos para modular la endoftalmitis utilizando fluoroquinolonas.
PH12014500057A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
MX2016006509A (es) Compuestos triciclicos de piperidina.

Legal Events

Date Code Title Description
FG Grant or registration